Viagra Spinoff Promising for Mild-to-Moderate PAH
17th Nov 2005, 19:47 GMT
BOLOGNA, Italy - A new formulation of Viagra (sildenafil) called Revatio appears safe and effective for treating mild-to-moderate symptomatic pulmonary arterial hypertension, but it may not be appropriate for patients with the severest disease.
Viagra Spinoff Promising for Mild-to-Moderate PAH related news:
- Viagra 100mg are Offered for Only $72.50 with Next Day FedEx Delivery — PR Web (The Free Wire Service) Medical Pharmaceuticals
- Pfizer Finds Viagra Spam Hard To Beat In Holland — Internet Security News
- Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia — Journal of Human Hypertension
- Move over Viagra: equal-opportunity sex drug just a sniff away — HEALTH
- Viagra can save a woman's heart! — KeralaNext: Health
- Viagra may be useful for serious lung disease — RedOrbit News - Health
- Move over Viagra: New love drug promises equal opportunity — The Times Of India - The United States
- Move over Viagra: equal-opportunity sex drug just a sniff away (AFP) — Yahoo! News: Health News
- Pfizer takes on Viagra spam in Holland — Channel Register - Security
- Hersteller startet Kampagne gegen Viagra-Spam — WinFuture.de
Latest news from MedPage Today Cardiovascular:
- AHA: Women Receive Less Cardiovascular Secondary Prevention
- AHA: Chest Protectors Have Fatal Flaws in Blocking Cardiac Arrest
- AHA: No Cardiovascular Benefit from Folic Acid and B Vitamins
- AHA: Attention from Pharmacist Improves Compliance for Older Patients
- AHA: Non-Invasive Office-Based Test Could Increase Appropriate Use of ICDs
- AHA: Human Atrial Natiuretic Peptide May Reduce Reperfusion Injury
- AHA: Blood Test Improves Management of Acute Heart Failure
- AHA: Novel Drug Effective for Hyponatremia in Heart Failure Patients